跳到主要导航 跳到搜索 跳到主要内容

Corrigendum to “RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer” [Cellular Signaling, 48 (2018) 38–44, (S0898656818300925), (10.1016/j.cellsig.2018.04.006)]

  • Ke Hui
  • , Shiqi Wu
  • , Yangyang Yue
  • , Yanan Gu
  • , Bing Guan
  • , Xinyang Wang
  • , Jer Tsong Hsieh
  • , Luke S. Chang
  • , Dalin He
  • , Kaijie Wu
  • The First Affiliated Hospital of Xi’an Jiaotong University
  • University of Texas Southwestern Medical Center

科研成果: 期刊稿件 › 评论/辩论

摘要

The authors regret that the representative picture (Fig. 2, panel B) to show the HUVECs tube formation from 253J-BV NC was misused (marked with a red box), which was same with 5637 KD1 (marked with a blue box). We have corrected this figure, and the conclusions are not changed.[Figure presented] The authors would like to apologize for any inconvenience caused.

源语言英语
期刊论文编号112730
期刊Cellular Signalling
DOI
出版状态已接受/待刊 - 2026
已对外发布是

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'Corrigendum to “RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer” [Cellular Signaling, 48 (2018) 38–44, (S0898656818300925), (10.1016/j.cellsig.2018.04.006)]' 的科研主题。它们共同构成独一无二的学术指纹。

引用此